Hot Flashes and Omega 3

NCT02062528 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 136

Last updated 2015-12-09

No results posted yet for this study

Summary

The main objective is to evaluate the effects of omega-3 fatty acids on hot flashes frequency.

Conditions

Interventions

DIETARY_SUPPLEMENT

omega-3 fatty acids

highly dosed in EPA

DIETARY_SUPPLEMENT

placebo

Sponsors & Collaborators

  • Centre d'Investigation Clinique de Grenoble CIC1406

    collaborator UNKNOWN
  • Vivatech

    lead INDUSTRY

Principal Investigators

  • Jean-Luc CRACOWSKI, MD-PhD · Centre d'investigation clinique CIC1406

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2015-05-31
Completion
2015-07-31

Countries

  • France

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02062528 on ClinicalTrials.gov